CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation

1. Bourla highlighted China's growing strength in biotechnology and pharmaceuticals. 2. AI may revolutionize drug discovery, boosting Pfizer's research capabilities. 3. Pfizer secured a three-year tariff exemption with the Trump administration. 4. Bourla called for U.S. regulatory changes to maintain competitive edge. 5. Scharf noted AI could lead to workforce reductions but increased productivity.